What Science Says About Ketamine’s Risks and Benefits
We’ll talk with experts about what we know — so far — about ketamine’s efficacy and safety.
August 26, 2024
55 min
Full
2,455 of 3,393
August 26, 2024
What Science Says About Ketamine’s Risks and Benefits
0:00 / 55:42
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
America the Jesuit Review Episodes Around August 26, 2024
Episode 2,455 of 3,393 — walk the feed in the order it was published.
55:42This episodeWhat Science Says About Ketamine’s Risks and Benefits
Summary
Ketamine is perhaps best known as a party drug, and it has long been used in hospitals as an anesthetic. In recent years, it has also been touted as a promising, experimental psychiatric treatment. But when Friends actor Matthew Perry overdosed on ketamine last year, it exposed a network of unregulated clinics and unscrupulous doctors distributing the drug for off-label uses. In this hour, we’ll talk with experts about what we know — so far — about ketamine’s efficacy and safety.
Guests:
Smita Das, clinical associate professor of psychiatry and behavioral sciences, Stanford Medicine; vice president of complex care and psychiatry, Lyra Health
Gerard Sanacora, professor of psychiatry and director, Yale Depression Research Program at the Yale School of Medicine
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.